Back to
UBS Group AG
NRIXShowing 8 of 22 quarters
Position history for
UBS Group AG's holdings in NURIX THERAPEUTICS INC
Yes. Ubs holds 917,117 shares of NRIX (Nurix Therapeutics), worth $22.2M, as of its Q2 2026 13F filing. It reduced the position by 59,245 shares (-6.1%) from Q1 2026. Ubs has held NRIX since Q1 2021, across 22 quarterly 13F filings.
Current Value
$22.2M
Current Shares
917,117
Total Value Change
+$19.9M
Total Shares Change
+814,251
Quarter-by-Quarter History
Other major holders of NRIX: BlackRock, Inc., FMR LLC